PGK1 and Parkinson disease: TZ slows or prevents neuronal loss, increases dopamine levels and partially restores motor function in MPTP mouse model, 6-OHDA rat model, and rotenone Drosophila model of PD, by potentiating PGK1 activity, enhancing glycolysis, and increasing cellular ATP levels.